LIDDS.ST Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 13:47):

LIDDS AB (publ), a pharmaceutical company, develops and sells pharmaceutical products for cancer and other diseases in Sweden. It is developing various drugs, such as NZ-2HOF to treat prostate cancer; NZ-DTX to treat breast, prostate, head, neck, stomach, and lung cancer; NZ-DOX for the treatment of solid tumors; NZ-IO, an immunotherapy; NZ-STING for the treatment of immuno-oncology; and NZ-TLR9 for enhancing cancer immunotherapies...

Stats
Dzisiejszy wolumen	50 000.00
Średni wolumen	93 805.00
Kapitalizacja rynkowa	10.92M
EPS	SEK0 ( 2024-02-21 )
Następna data zysków	( SEK0 ) 2024-05-27
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.270
ATR14	SEK0.00200 (1.25%)

LIDDS AB (publ) Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

LIDDS AB (publ) Finanse

Annual	2023
Przychody:	SEK0
Zysk brutto:	SEK-15.69M (0.00 %)
EPS:	SEK-0.630

FY	2023
Przychody:	SEK0
Zysk brutto:	SEK-15.69M (0.00 %)
EPS:	SEK-0.630

FY	2023
Przychody:	SEK0
Zysk brutto:	SEK0 (0.00 %)
EPS:	SEK0

FY	2022
Przychody:	SEK1.89M
Zysk brutto:	SEK-36.62M (-1 939.62 %)
EPS:	SEK-1.000

Financial Reports:

No articles found.

LIDDS AB (publ)